Delivery Order SPE2DB25D3003-SPE2DB25FPXCU
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Cipro 500 mg tablets (100-count units) at a ceiling value of $1,185.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 14, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Cipro 500 mg tablets (100-count units) valued at $1,186.55. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside, competitively awarded contract and reflects the agency's continued reliance on AmerisourceBergen as a critical pharmaceutical vendor for federal medical procurement. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cipro 500 mg tablets (100 count) at a ceiling value of $1,567.80. This competitive, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cipro (ciprofloxacin) 250 mg tablets in quantities of 100 units, with a contract ceiling value of $1,564.92. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a pediatric or smaller-quantity pharmaceutical procurement utilizing AmerisourceBergen's existing contract vehicle. The award was not designated as a set-aside and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cipro 500 mg tablets (100-count packages) under a firm fixed-price contract with a ceiling value of $2,351.70. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 28, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Cipro 500 mg tablets (100-count units) with a ceiling value of $1,175.85. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside procurement issued to the prime contractor at its Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract with...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 8, 2025, for Cipro 500 mg tablets (100-count) with a ceiling value of $3,275.23. This firm fixed price delivery order, which is due for completion by August 11, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Ciprofloxacin HCL 500 mg tablets in quantities of 100, with a ceiling value of $1,019.21. This is a firm fixed price, non-set-aside delivery order that will be completed by August 28, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Cipro 500 mg, with a ceiling value of $2,754.95. This order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a competitive award with firm fixed-price terms. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin HCl 500 mg tablets (100 count) valued at $1,850.73 on August 27, 2025, with completion targeted for August 28, 2025. This non-competitive, firm fixed-price delivery order represents a relatively small-value pharmaceutical procurement typical of routine medical supply replenishment. The award was made to AmerisourceBergen's Corporate Office division, located in Conshohocken,...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXCUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,175.85 to AmerisourceBergen Drug Corp for 100 tablets of Cipro 500 mg on September 9, 2025, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order for the antibiotic Cipro exemplifies the routine pharmaceutical procurement activities executed under AmerisourceBergen's comprehensive DLA Troop Support Medical contract, which enables the company to fulfill federal medical supply needs globally. The company's position as a prime vendor reflects its demonstrated capability to meet federal procurement requirements through open competition and its extensive portfolio serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical contract represents a flexible vehicle designed to support military healthcare operations worldwide with essential pharmaceuticals and medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/9/25 |